20,000+ Scientists & Academics
4,000+ Scientific disciplines
20,000+ Projects posted
Trusted by 3,200+ businesses
Why Kolabtree
Getting started is quick and easy. No upfront fees
It’s free to request a service and invite bids from experts
Discuss the project scope and fee and hire the expert who best meets your requirements
Collaborate with the expert directly to get your work done the right way
Fund project when you hire the expert, but release the funds only once work is done
Want to hire this expert for a project? Request a quote for free.
Profile Details
Hire Dr. Stanley Kimani
United States
Profile Summary
Subject Matter Expertise
Work Experience

Assistant Professor (Adjunct) - Biology of Cancer and Molecular Biology of the Gene

Kean University, 1000 Morris Ave, Union, NJ

January 2015 - October 2016

Postdoctoral Research Fellow

Rutgers-New Jersey Medical School, Newark, NJ

October 2012 - October 2016

Postdoctoral Research Fellow

Harvard Medical School/Massachusetts General Hospital, Boston, MA

April 2011 - June 2012

Research Associate

Uppsala University, Uppsala, Sweden

June 2006 - September 2007


Ph.D. Cancer Biology

Open University, Milton Keynes, United Kingdom

September 2007 - April 2011

Ph.D. (Life Sciences)

Open University

September 2007 - April 2011

MSc. Molecular Biology

University of Skovde, Skovde, Sweden

January 2005 - June 2006

BSc. Biomedical Sciences (Department of Biomedical Sciences)

Maseno University

September 1999 - December 2003

  • Certification details not provided.
Ke Geng, Sushil Kumar, Stanley G. Kimani, Vladyslav Kholodovych, Canan Kasikara, Kensaku Mizuno, Oleta Sandiford, Pranela Rameshwar, Sergei V. Kotenko, Raymond B. Birge(2017). Requirement of Gamma-Carboxyglutamic Acid Modification and Phosphatidylserine Binding for the Activation of Tyro3, Axl, and Mertk Receptors by Growth Arrest-Specific 6 . Frontiers in Immunology. 8. Frontiers Media {SA}
Stanley G. Kimani, Sushil Kumar, Nitu Bansal, Kamalendra Singh, Vladyslav Kholodovych, Thomas Comollo, Youyi Peng, Sergei V. Kotenko, Stefan G. Sarafianos, Joseph R. Bertino, et al.(2017). Small molecule inhibitors block Gas6-inducible {TAM} activation and tumorigenicity . Scientific Reports. 7. (1). Springer Nature
Stanley Kimani, Canan Kasikara, Sushil Kumar, Wen-I Tsou, Ke Geng, Viralkumar Davra, Ganapathy Sriram, Connor Devoe, Khanh-Quynh N. Nguyen, Anita Antes, et al.(2017). Phosphatidylserine Sensing by {TAM} Receptors Regulates {AKT}-Dependent Chemoresistance and {PD}-L1 Expression . Molecular Cancer Research. 15. (6). p. 753--764. American Association for Cancer Research ({AACR})
Stanley Kimani, Viralkumar Davra, David Calianese, Raymond Birge(2016). Ligand Activation of {TAM} Family Receptors-Implications for Tumor Biology and Therapeutic Response . Cancers. 8. (12). p. 107. {MDPI} {AG}
Stanley Kimani, Nitu Bansal, Kamlendra Singh, Thomas Comollo, Sushil Kumar, Vladyslav Kholodovych, Youyi Peng, William Welsh, Bertino Joseph, Raymond B. Birge(2016). Abstract 348: Small molecule Axl Ig1-Gas6 inhibitors block Gas6-inducible Axl signaling and suppress tumorigenicity . Cancer Research. 76. (14 Supplement). p. 348--348. American Association for Cancer Research ({AACR})
Stanley Gititu Kimani, Ke Geng, Canan Kasikara, Sushil Kumar, Ganapathy Sriram, Yi Wu, Raymond B. Birge(2014). Contribution of Defective {PS} Recognition and Efferocytosis to Chronic Inflammation and Autoimmunity . Frontiers in Immunology. 5. Frontiers Media {SA}
Stanley Kimani, Shelly Hsieh, Khanh Q. Nguyen, Raymond B. Birge(2014). Abstract 143: Non-canonical role of {TAM} receptors in breast cancer . Cancer Research. 74. (19 Supplement). p. 143--143. American Association for Cancer Research ({AACR})
Stanley Kimani, William J. Welsh, Vladyslav Kholodovych, Raymond Birge, Tom Comollo, Kamal Singh(2014). Abstract 1748: Novel Ig1 inhibitors of the Axl tyrosine kinase that block Gas6-inducible receptor activation . Cancer Research. 74. (19 Supplement). p. 1748--1748. American Association for Cancer Research ({AACR})
Khanh-Quynh N. Nguyen, Wen-I Tsou, Daniel A. Calarese, Stanley G. Kimani, Sukhwinder Singh, Shelly Hsieh, Yongzhang Liu, Bin Lu, Yi Wu, Scott J. Garforth, et al.(2014). Overexpression of {MERTK} Receptor Tyrosine Kinase in Epithelial Cancer Cells Drives Efferocytosis in a Gain-of-Function Capacity . Journal of Biological Chemistry. 289. (37). p. 25737--25749. American Society for Biochemistry {\&} Molecular Biology ({ASBMB})
Stanley Kimani, Ashwini Ghogare, Goutam Ghosh, Dorota Bartusik, Benjamin Rudshteyn, Tayyaba Hasan, Alexander Greer(2013). Abstract 2481: Synthesis and characterization of {PEGylated} chlorin e6 sensitizers for the photodynamic killing of human ovarian cancer cells . Cancer Research. 73. (8 Supplement). p. 2481--2481. American Association for Cancer Research ({AACR})
Stanley Kimani, Goutam Ghosh, Ashwini Ghogare, Benjamin Rudshteyn, Dorota Bartusik, Tayyaba Hasan, Alexander Greer(2012). Synthesis and Characterization of Mono-, Di-, and Tri-Poly(ethylene glycol) Chlorin e6 Conjugates for the Photokilling of Human Ovarian Cancer Cells . The Journal of Organic Chemistry. 77. (23). p. 10638--10647. American Chemical Society ({ACS})
Stanley G. Kimani, James B. Phillips, James I. Bruce, Alexander J. MacRobert, Jon P. Golding(2011). Antioxidant Inhibitors Potentiate the Cytotoxicity of Photodynamic Therapy . Photochemistry and Photobiology. 88. (1). p. 175--187. Wiley
Tijs van Wieringen, Stanley G. Kimani, Anna-Karin Hultgård-Ekwall, Jens Forsberg, Vahid Reyhani, Åke Engström, Kristofer Rubin(2009). Opposite effects of {PDGF}-{BB} and prostaglandin E1 on cell-motility related processes are paralleled by modifications of distinct actin-binding proteins . Experimental Cell Research. 315. (10). p. 1745--1758. Elsevier {BV}
Stanley Kimani, Lei Zheng, R Sears, Iqbal Massodi, Tayyaba Hasan(2013). Enhancing Photodynamic Treatment of Cancer with Mechanism-Based Combination Strategies . 353--366Taylor {\&}amp$\mathsemicolon$ Francis